Cargando…
Preclinical Studies of the Off-Target Reactivity of AFP(158)-Specific TCR Engineered T Cells
Autologous T cells engineered with T receptor genes (TCR) are being studied to treat cancers. We have recently identified a panel of mouse TCRs specific for the HLA-A0201/alpha fetoprotein epitope (AFP(158)) complex and have shown that human T cells engineered with these TCR genes (TCR-Ts) can eradi...
Autores principales: | Cai, Lun, Caraballo Galva, Leidy D., Peng, Yibing, Luo, Xiaobing, Zhu, Wei, Yao, Yihong, Ji, Yun, He, Yukai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196607/ https://www.ncbi.nlm.nih.gov/pubmed/32395117 http://dx.doi.org/10.3389/fimmu.2020.00607 |
Ejemplares similares
-
Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit
por: Luo, Xiaobing, et al.
Publicado: (2020) -
Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes
por: Sun, Longhao, et al.
Publicado: (2016) -
TCR T cells overexpressing c-Jun have better functionality with improved tumor infiltration and persistence in hepatocellular carcinoma
por: Hussein, Mohamed S., et al.
Publicado: (2023) -
TCR Fingerprinting and Off-Target Peptide Identification
por: Karapetyan, Armen R., et al.
Publicado: (2019) -
Emerging Strategies in TCR-Engineered T Cells
por: Wei, Fang, et al.
Publicado: (2022)